Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × Solid Malignancies × ixabepilone × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 19 Neoplasms 8 Neoplasm Metastasis 5 Unspecified Adult Solid Tumor, Protocol Specific 1 Stomach Neoplasms 1 Solid Tumors 1 Solid Malignancies 1 Recurrence 1 Pancreatic Neoplasms 1 Lung Neoplasms 1 Endometrial Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma 1 Advanced Solid Tumors 1

Interventions

ixabepilone 1 ST 1481 1 Paclitaxel 1 Fulvestrant 1 Docetaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00162136 2020-11-02

Clinical Study of Ixabepilone Administered as a 24 Hour Infusion in Patients With Solid Malignancies.

R-Pharm

Phase 1 Completed

35 enrolled 17 charts

Solid Malignancies

Data powered by HemOnc (CC BY 4.0) Colophon ⚡